Daiichi Sankyo Co Ltd (DSNKY)
34.49
+0.85
(+2.53%)
USD |
OTCM |
May 10, 16:00
Daiichi Sankyo Net Income (Quarterly): 250.42M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 250.42M |
December 31, 2023 | 450.77M |
September 30, 2023 | 276.87M |
June 30, 2023 | 415.49M |
March 31, 2023 | 170.25M |
December 31, 2022 | 201.38M |
September 30, 2022 | 285.62M |
June 30, 2022 | 145.48M |
March 31, 2022 | -235.39M |
December 31, 2021 | 280.21M |
September 30, 2021 | 247.53M |
June 30, 2021 | 321.77M |
March 31, 2021 | 1.435M |
December 31, 2020 | 231.13M |
September 30, 2020 | 186.65M |
June 30, 2020 | 296.04M |
March 31, 2020 | -47.81M |
December 31, 2019 | 642.42M |
September 30, 2019 | 196.51M |
June 30, 2019 | 394.39M |
March 31, 2019 | 132.67M |
December 31, 2018 | 308.53M |
September 30, 2018 | 180.00M |
June 30, 2018 | 219.59M |
March 31, 2018 | -113.65M |
Date | Value |
---|---|
December 31, 2017 | 339.33M |
September 30, 2017 | 46.21M |
June 30, 2017 | 262.38M |
March 31, 2017 | -305.30M |
December 31, 2016 | 359.15M |
September 30, 2016 | 179.62M |
June 30, 2016 | 283.34M |
March 31, 2016 | -246.87M |
December 31, 2015 | 329.54M |
September 30, 2015 | 292.71M |
June 30, 2015 | 287.97M |
March 31, 2015 | 1.845B |
December 31, 2014 | 453.89M |
September 30, 2014 | 291.90M |
June 30, 2014 | 195.65M |
March 31, 2014 | -102.01M |
December 31, 2013 | 377.96M |
September 30, 2013 | 186.65M |
June 30, 2013 | 152.13M |
March 31, 2013 | 136.03M |
December 31, 2012 | 334.29M |
September 30, 2012 | 50.23M |
June 30, 2012 | 254.57M |
March 31, 2012 | -90.37M |
December 31, 2011 | -252.02M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-235.39M
Minimum
Mar 2022
642.42M
Maximum
Dec 2019
235.56M
Average
248.98M
Median
Net Income (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | -20.33M |
Nxera Pharma Co Ltd | -22.11M |
PeptiDream Inc | -3.424M |
Healios KK | -11.72M |
AnGes Inc | -17.88M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 2.887B |
Total Expenses (Quarterly) | 2.772B |
EPS Diluted (Quarterly) | 0.1305 |
Enterprise Value | 58.72B |
Gross Profit Margin (Quarterly) | 75.59% |
Profit Margin (Quarterly) | 8.68% |
Earnings Yield | 2.11% |
Operating Earnings Yield | 2.21% |
Normalized Earnings Yield | 2.106 |